Machine learning assessment of vildagliptin and linagliptin effectiveness in type 2 diabetes: Predictors of glycemic control.

Hanin A EsaifanLoai M SaadahKhawla Abu HammourRana K Abu Farha

Published in: PloS one (2024)

Linagliptin effectively lowers HbA1c levels more than vildagliptin including in patients with comorbidities. DPP4-I choice is a constant predictor of HbA1c in all models.

Keyphrases

glycemic control
type diabetes
machine learning
blood glucose
randomized controlled trial
systematic review
weight loss
insulin resistance
artificial intelligence
big data
cardiovascular disease
deep learning
decision making
metabolic syndrome
skeletal muscle